6,9,11-trihydroxy-9-(2-hydroxyacetyl)-7-[5-hydroxy-6-methyl-4-(pyridin-3-ylmethylamino)oxan-2-yl]oxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
-
6,9,11-trihydroxy-9-(2-hydroxyacetyl)-7-[5-hydroxy-6-methyl-4-(pyridin-3-ylmethylamino)oxan-2-yl]oxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
structure -
-
CAS No:
145785-62-2
-
Formula:
C33H34N2O11
-
Chemical Name:
6,9,11-trihydroxy-9-(2-hydroxyacetyl)-7-[5-hydroxy-6-methyl-4-(pyridin-3-ylmethylamino)oxan-2-yl]oxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
-
Synonyms:
N-(3-pyridylmethyl)adriamycin;YM 1;YM-1;YM1 doxorubicin analog;145785-62-2;YM1 Doxorubicin analog;N-(3-Pyridylmethyl)adriamycin;YM3 Doxorubicin analog;YM 1;YM 3;N-(3-Pyridylmethyl)epidoxorubicin;145843-38-5;DTXSID20932692;3,5,12-Trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 2,3,6-trideoxy-3-{[(pyridin-3-yl)methyl]amino}hexopyranoside;5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-10-((2,3,6-trideoxy-3-((3-pyridinylmethyl)amino)-alpha-L-arabino-hexopyranosyl)oxy)-, (8S-cis)-;5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-10-((2,3,6-trideoxy-3-((3-pyridinylmethyl)amino)-alpha-L-lyxo-hexopyranosyl)oxy)-, (8S-cis)-
-
CAS No:
6,9,11-trihydroxy-9-(2-hydroxyacetyl)-7-[5-hydroxy-6-methyl-4-(pyridin-3-ylmethylamino)oxan-2-yl]oxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione Basic Attributes
634.6 g/mol
634.21625990 g/mol
Computed Properties
Molecular Weight:634.6
XLogP3:2.2
Hydrogen Bond Donor Count:6
Hydrogen Bond Acceptor Count:13
Rotatable Bond Count:8
Exact Mass:634.21625990
Monoisotopic Mass:634.21625990
Topological Polar Surface Area:205
Heavy Atom Count:46
Complexity:1140
Undefined Atom Stereocenter Count:6
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Request for Quotation